DUBLIN, March 19, 2021 /PRNewswire/ -- Cosmo
Pharmaceuticals NV (SIX: COPN) invites investors, financial
analysts and business/lifescience journalists for a telephone
conference on 26 March 2021 with CEO
Alessandro Della Chà and CFO Niall
Donnelly to discuss the 2020 results and 2021 outlook of the
company.
Date: Friday, 26 March
2021
Time: 02:00 pm
CET
Dial-in numbers:
Switzerland / Europe: +41 (0) 58 310 50 00
United Kingdom: +44 (0) 207 107 06
13
United States: +1 (1) 631 570 56
13
The presentation and press release as well as the Annual Report
2020 will be available for download as of 07:00 am CET on 26 March
2021 on www.cosmopharma.com
About Cosmo Pharmaceuticals
Cosmo is a specialty pharmaceutical company focused on
developing and commercialising products to treat selected
gastrointestinal disorders and improve endoscopy quality measures
through aiding the detection of colonic lesions. Cosmo has also
developed medical devices for endoscopy and has recently entered
into a partnership with Medtronic for the global distribution of GI
Genius™ its artificial intelligence device for use in
coloscopies and GI procedures. Cosmo has licensed
Aemcolo® to Red Hill Biopharma Ltd.
for the US and has licensed
Relafalk® to Dr. Falk Gmbh for the EU
and other countries. For additional information on Cosmo and its
products please visit the Company's website:
www.cosmopharma.com
Calendar
2020 Full Year Results and 2021 Outlook -
March 26, 2021
Annual General Meeting, Amsterdam
- May 28, 2021
View original content to download
multimedia:http://www.prnewswire.com/news-releases/invitation-to-cosmos-2020-results--2021-outlook-presentation-conference-call-on-26-march-2021-301250513.html
SOURCE Cosmo Pharmaceuticals N.V.
